Household & Personal Products
Compare Stocks
3 / 10Stock Comparison
CHD vs PG vs CL
Revenue, margins, valuation, and 5-year total return — side by side.
Household & Personal Products
Household & Personal Products
CHD vs PG vs CL — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||
|---|---|---|---|
| Industry | Household & Personal Products | Household & Personal Products | Household & Personal Products |
| Market Cap | $22.15B | $338.64B | $69.26B |
| Revenue (TTM) | $6.21B | $86.72B | $20.38B |
| Net Income (TTM) | $733M | $12.72B | $2.13B |
| Gross Margin | 45.1% | 50.3% | 60.1% |
| Operating Margin | 17.3% | 23.2% | 21.3% |
| Forward P/E | 24.9x | 21.0x | 22.6x |
| Total Debt | $2.21B | $35.46B | $7.99B |
| Cash & Equiv. | $409M | $9.56B | $1.29B |
CHD vs PG vs CL — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Church & Dwight Co.… (CHD) | 100 | 124.6 | +24.6% |
| The Procter & Gambl… (PG) | 100 | 125.0 | +25.0% |
| Colgate-Palmolive C… (CL) | 100 | 119.4 | +19.4% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CHD vs PG vs CL
Each card shows where this stock fits in a portfolio — not just who wins on paper.
CHD is the clearest fit if your priority is growth exposure and sleep-well-at-night.
- Rev growth 1.6%, EPS growth 27.4%, 3Y rev CAGR 4.9%
- Lower volatility, beta 0.14, Low D/E 55.1%, current ratio 1.07x
- 1.6% revenue growth vs PG's 0.3%
PG carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 36 yrs, beta 0.10, yield 2.8%
- 120.1% 10Y total return vs CHD's 117.3%
- Beta 0.10, yield 2.8%, current ratio 0.70x
CL is the clearest fit if your priority is efficiency.
- 12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9%
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 1.6% revenue growth vs PG's 0.3% | |
| Value | Lower P/E (21.0x vs 24.9x) | |
| Quality / Margins | 14.7% margin vs CL's 10.5% | |
| Stability / Safety | Beta 0.10 vs CHD's 0.14 | |
| Dividends | 2.8% yield, 36-year raise streak, vs CHD's 1.3% | |
| Momentum (1Y) | +2.1% vs PG's -6.1% | |
| Efficiency (ROA) | 12.5% ROA vs CHD's 8.2%, ROIC 43.4% vs 13.9% |
CHD vs PG vs CL — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
CHD vs PG vs CL — Financial Metrics
Side-by-side numbers across 3 stocks — who leads on profitability, valuation, growth, and risk.
Income & Cash Flow (Last 12 Months)
PG leads this category, winning 4 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
PG is the larger business by revenue, generating $86.7B annually — 14.0x CHD's $6.2B. Profitability is closely matched — net margins range from 14.7% (PG) to 10.5% (CL). On growth, PG holds the edge at +7.4% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||
|---|---|---|---|
| RevenueTrailing 12 months | $6.2B | $86.7B | $20.4B |
| EBITDAEarnings before interest/tax | $1.3B | $21.9B | $3.9B |
| Net IncomeAfter-tax profit | $733M | $12.7B | $2.1B |
| Free Cash FlowCash after capex | $1.1B | $15.0B | $3.6B |
| Gross MarginGross profit ÷ Revenue | +45.1% | +50.3% | +60.1% |
| Operating MarginEBIT ÷ Revenue | +17.3% | +23.2% | +21.3% |
| Net MarginNet income ÷ Revenue | +11.8% | +14.7% | +10.5% |
| FCF MarginFCF ÷ Revenue | +17.2% | +17.3% | +17.8% |
| Rev. Growth (YoY)Latest quarter vs prior year | +0.1% | +7.4% | +5.8% |
| EPS Growth (YoY)Latest quarter vs prior year | +2.2% | +5.8% | -105.1% |
Valuation Metrics
CL leads this category, winning 3 of 6 comparable metrics.
Valuation Metrics
At 22.3x trailing earnings, PG trades at a 32% valuation discount to CL's 32.8x P/E. On an enterprise value basis, CL's 15.3x EV/EBITDA is more attractive than CHD's 18.1x.
| Metric | |||
|---|---|---|---|
| Market CapShares × price | $22.2B | $338.6B | $69.3B |
| Enterprise ValueMkt cap + debt − cash | $24.0B | $364.5B | $76.0B |
| Trailing P/EPrice ÷ TTM EPS | 30.97x | 22.26x | 32.83x |
| Forward P/EPrice ÷ next-FY EPS est. | 24.91x | 20.97x | 22.61x |
| PEG RatioP/E ÷ EPS growth rate | — | 3.98x | — |
| EV / EBITDAEnterprise value multiple | 18.08x | 15.65x | 15.26x |
| Price / SalesMarket cap ÷ Revenue | 3.57x | 4.02x | 3.40x |
| Price / BookPrice ÷ Book value/share | 5.71x | 6.80x | 191.84x |
| Price / FCFMarket cap ÷ FCF | 20.27x | 24.11x | 19.06x |
Profitability & Efficiency
Evenly matched — CHD and CL each lead in 4 of 9 comparable metrics.
Profitability & Efficiency
CL delivers a 2.5% return on equity — every $100 of shareholder capital generates $3 in annual profit, vs $17 for CHD. CHD carries lower financial leverage with a 0.55x debt-to-equity ratio, signaling a more conservative balance sheet compared to CL's 21.88x. On the Piotroski fundamental quality scale (0–9), CHD scores 7/9 vs PG's 5/9, reflecting strong financial health.
| Metric | |||
|---|---|---|---|
| ROE (TTM)Return on equity | +17.4% | +23.8% | +2.5% |
| ROA (TTM)Return on assets | +8.2% | +10.0% | +12.5% |
| ROICReturn on invested capital | +13.9% | +20.1% | +43.4% |
| ROCEReturn on capital employed | +14.4% | +23.0% | +41.6% |
| Piotroski ScoreFundamental quality 0–9 | 7 | 5 | 6 |
| Debt / EquityFinancial leverage | 0.55x | 0.68x | 21.88x |
| Net DebtTotal debt minus cash | $1.8B | $25.9B | $6.7B |
| Cash & Equiv.Liquid assets | $409M | $9.6B | $1.3B |
| Total DebtShort + long-term debt | $2.2B | $35.5B | $8.0B |
| Interest CoverageEBIT ÷ Interest expense | 15.59x | 487.21x | 12.37x |
Total Returns (Dividends Reinvested)
Evenly matched — CHD and PG and CL each lead in 2 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in PG five years ago would be worth $12,310 today (with dividends reinvested), compared to $11,219 for CHD. Over the past 12 months, CHD leads with a +2.1% total return vs PG's -6.1%. The 3-year compound annual growth rate (CAGR) favors CL at 4.7% vs CHD's -0.2% — a key indicator of consistent wealth creation.
| Metric | |||
|---|---|---|---|
| YTD ReturnYear-to-date | +13.5% | +3.7% | +12.5% |
| 1-Year ReturnPast 12 months | +2.1% | -6.1% | -2.6% |
| 3-Year ReturnCumulative with dividends | -0.6% | +0.7% | +14.6% |
| 5-Year ReturnCumulative with dividends | +12.2% | +23.1% | +18.2% |
| 10-Year ReturnCumulative with dividends | +117.3% | +120.1% | +46.2% |
| CAGR (3Y)Annualised 3-year return | -0.2% | +0.2% | +4.7% |
Risk & Volatility
Evenly matched — CHD and CL each lead in 1 of 2 comparable metrics.
Risk & Volatility
CL is the less volatile stock with a -0.00 beta — it tends to amplify market swings less than CHD's 0.14 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CHD currently trades 88.2% from its 52-week high vs PG's 84.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||
|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.14x | 0.10x | -0.00x |
| 52-Week HighHighest price in past year | $106.04 | $170.99 | $99.33 |
| 52-Week LowLowest price in past year | $81.33 | $137.62 | $74.55 |
| % of 52W HighCurrent price vs 52-week peak | +88.2% | +84.8% | +86.9% |
| RSI (14)Momentum oscillator 0–100 | 41.6 | 43.4 | 50.1 |
| Avg Volume (50D)Average daily shares traded | 1.9M | 7.3M | 5.6M |
Analyst Outlook
PG leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: CHD as "Buy", PG as "Buy", CL as "Hold". Consensus price targets imply 11.7% upside for PG (target: $162) vs 6.5% for CHD (target: $100). For income investors, PG offers the higher dividend yield at 2.78% vs CHD's 1.26%.
| Metric | |||
|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $99.60 | $161.88 | $93.70 |
| # AnalystsCovering analysts | 34 | 52 | 45 |
| Dividend YieldAnnual dividend ÷ price | +1.3% | +2.8% | +2.6% |
| Dividend StreakConsecutive years of raises | 23 | 36 | 5 |
| Dividend / ShareAnnual DPS | $1.18 | $4.02 | $2.25 |
| Buyback YieldShare repurchases ÷ mkt cap | +4.1% | +1.9% | +1.7% |
PG leads in 2 of 6 categories (Income & Cash Flow, Analyst Outlook). CL leads in 1 (Valuation Metrics). 3 tied.
CHD vs PG vs CL: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is CHD or PG or CL a better buy right now?
For growth investors, Church & Dwight Co.
, Inc. (CHD) is the stronger pick with 1. 6% revenue growth year-over-year, versus 0. 3% for The Procter & Gamble Company (PG). The Procter & Gamble Company (PG) offers the better valuation at 22. 3x trailing P/E (21. 0x forward), making it the more compelling value choice. Analysts rate Church & Dwight Co. , Inc. (CHD) a "Buy" — based on 34 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CHD or PG or CL?
On trailing P/E, The Procter & Gamble Company (PG) is the cheapest at 22.
3x versus Colgate-Palmolive Company at 32. 8x. On forward P/E, The Procter & Gamble Company is actually cheaper at 21. 0x.
03Which is the better long-term investment — CHD or PG or CL?
Over the past 5 years, The Procter & Gamble Company (PG) delivered a total return of +23.
1%, compared to +12. 2% for Church & Dwight Co. , Inc. (CHD). Over 10 years, the gap is even starker: PG returned +120. 1% versus CL's +46. 2%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CHD or PG or CL?
By beta (market sensitivity over 5 years), Colgate-Palmolive Company (CL) is the lower-risk stock at -0.
00β versus Church & Dwight Co. , Inc. 's 0. 14β — meaning CHD is approximately -3261% more volatile than CL relative to the S&P 500. On balance sheet safety, Church & Dwight Co. , Inc. (CHD) carries a lower debt/equity ratio of 55% versus 22% for Colgate-Palmolive Company — giving it more financial flexibility in a downturn.
05Which is growing faster — CHD or PG or CL?
By revenue growth (latest reported year), Church & Dwight Co.
, Inc. (CHD) is pulling ahead at 1. 6% versus 0. 3% for The Procter & Gamble Company (PG). On earnings-per-share growth, the picture is similar: Church & Dwight Co. , Inc. grew EPS 27. 4% year-over-year, compared to -25. 1% for Colgate-Palmolive Company. Over a 3-year CAGR, CHD leads at 4. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CHD or PG or CL?
The Procter & Gamble Company (PG) is the more profitable company, earning 19.
0% net margin versus 10. 5% for Colgate-Palmolive Company — meaning it keeps 19. 0% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: PG leads at 24. 3% versus 17. 4% for CHD. At the gross margin level — before operating expenses — CL leads at 60. 1%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CHD or PG or CL more undervalued right now?
On forward earnings alone, The Procter & Gamble Company (PG) trades at 21.
0x forward P/E versus 24. 9x for Church & Dwight Co. , Inc. — 3. 9x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for PG: 11. 7% to $161. 88.
08Which pays a better dividend — CHD or PG or CL?
All stocks in this comparison pay dividends.
The Procter & Gamble Company (PG) offers the highest yield at 2. 8%, versus 1. 3% for Church & Dwight Co. , Inc. (CHD).
09Is CHD or PG or CL better for a retirement portfolio?
For long-horizon retirement investors, Colgate-Palmolive Company (CL) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β -0.
00), 2. 6% yield). Both have compounded well over 10 years (CL: +46. 2%, CHD: +117. 3%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CHD and PG and CL?
Both stocks operate in the Consumer Defensive sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.